$85.37
0.91%
Nasdaq, Oct 02, 04:00 pm EDT. Closed.

Merit Medical Systems, Inc. Target price 2026 - Analyst rating & recommendation

Merit Medical Systems, Inc. Classifications & Recommendation

Buy
82%
Hold
18%

Merit Medical Systems, Inc. Price Target

Target Price $102.00
Price $85.37
Potential
Number of Estimates 13
13 Analysts have issued a price target Merit Medical Systems, Inc. 2027 . The average Merit Medical Systems, Inc. target price is $102.00. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 17 analysts: 14 Analysts recommend Merit Medical Systems, Inc. to buy, 3 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Merit Medical Systems, Inc. stock has an average upside potential 2027 of . Most analysts recommend the Merit Medical Systems, Inc. stock at Purchase.

Sales and Margin forecast 2026, 2027 to 2030

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Revenue Billion $ 1.52 1.67
11.75% 10.10%
EBITDA Margin 20.85% 25.34%
5.98% 21.53%
Net Margin 8.48% 15.70%
4.47% 85.23%

13 Analysts have issued a sales forecast Merit Medical Systems, Inc. 2026 . The average Merit Medical Systems, Inc. sales estimate is

$1.7b
unlock
. This is
5.71% higher
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$1.7b 8.94%
unlock
, the lowest is
$1.6b 1.28%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 $1.5b 11.75%
2026
$1.7b 10.10%
unlock
2027
$1.8b 6.11%
unlock
2028
$1.9b 5.87%
unlock
2029
$2.0b 6.24%
unlock
2030
$2.1b 5.97%
unlock

9 Analysts have issued an Merit Medical Systems, Inc. EBITDA forecast 2026. The average Merit Medical Systems, Inc. EBITDA estimate is

$423m
unlock
. This is
24.45% higher
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$457m 34.55%
unlock
, the lowest is
$381m 12.17%
unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 $316m 18.43%
2026
$423m 33.81%
unlock
2027
$467m 10.31%
unlock
2028
$516m 10.51%
unlock
2029
$544m 5.47%
unlock
2030
$588m 8.07%
unlock

EBITDA Margin

2025 20.85% 5.98%
2026
25.34% 21.53%
unlock
2027
26.34% 3.95%
unlock
2028
27.50% 4.40%
unlock
2029
27.30% 0.73%
unlock
2030
27.84% 1.98%
unlock

13 Merit Medical Systems, Inc. Analysts have issued a net profit forecast 2026. The average Merit Medical Systems, Inc. net profit estimate is

$262m
unlock
. This is
80.00% higher
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$271m 86.07%
unlock
, the lowest is
$250m 72.06%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 $128m 6.75%
2026
$262m 103.91%
unlock
2027
$281m 7.21%
unlock
2028
$302m 7.61%
unlock
2029
$316m 4.68%
unlock
2030
$336m 6.06%
unlock

Net Margin

2025 8.48% 4.47%
2026
15.70% 85.23%
unlock
2027
15.86% 1.02%
unlock
2028
16.12% 1.64%
unlock
2029
15.88% 1.49%
unlock
2030
15.90% 0.13%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2030

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Earnings Per Share $ 2.13 4.39
4.93% 106.10%
P/E 19.46
EV/Sales 3.23

13 Analysts have issued a Merit Medical Systems, Inc. forecast for earnings per share. The average Merit Medical Systems, Inc. EPS is

$4.39
unlock
. This is
80.66% higher
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
$4.54 86.83%
unlock
, the lowest is
$4.19 72.43%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 $2.13 4.93%
2026
$4.39 106.10%
unlock
2027
$4.70 7.06%
unlock
2028
$5.06 7.66%
unlock
2029
$5.30 4.74%
unlock
2030
$5.62 6.04%
unlock

P/E ratio

Current 35.13 13.70%
2026
19.46 44.61%
unlock
2027
18.15 6.73%
unlock
2028
16.86 7.11%
unlock
2029
16.11 4.45%
unlock
2030
15.19 5.71%
unlock

Based on analysts' sales estimates for 2026, the Merit Medical Systems, Inc. stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 3.41 5.01%
2026
3.23 5.38%
unlock
2027
3.04 5.76%
unlock
2028
2.87 5.55%
unlock
2029
2.70 5.87%
unlock
2030
2.55 5.64%
unlock

P/S ratio

Current 3.23 2.59%
2026
3.05 5.40%
unlock
2027
2.88 5.76%
unlock
2028
2.72 5.54%
unlock
2029
2.56 5.87%
unlock
2030
2.41 5.64%
unlock

Current Merit Medical Systems, Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Needham
Locked
➜
Locked
Locked Sep 29 2026
B of A Securities
Locked
➜
Locked
Locked Aug 13 2026
BTIG
Locked
➜
Locked
Locked Aug 11 2026
Canaccord Genuity
Locked
➜
Locked
Locked Aug 03 2026
Needham
Locked
➜
Locked
Locked Jul 31 2026
Wells Fargo
Locked
➜
Locked
Locked Jul 31 2026
JP Morgan
Locked
➜
Locked
Locked Jul 31 2026
Analyst Rating Date
Locked
Needham:
Locked
➜
Locked
Sep 29 2026
Locked
B of A Securities:
Locked
➜
Locked
Aug 13 2026
Locked
BTIG:
Locked
➜
Locked
Aug 11 2026
Locked
Canaccord Genuity:
Locked
➜
Locked
Aug 03 2026
Locked
Needham:
Locked
➜
Locked
Jul 31 2026
Locked
Wells Fargo:
Locked
➜
Locked
Jul 31 2026
Locked
JP Morgan:
Locked
➜
Locked
Jul 31 2026

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today